Aptamers to β-NGF and their use in treating β-NGF mediated diseases and disorders
US8598140B2 · kind B2 · utility
15Cited by
29References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 12, 2011 |
| Grant date | Dec 3, 2013 |
| Priority date | — |
| Expiry date | Apr 12, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/335
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to β-NGF; pharmaceutical compositions comprising such β-NGF aptamers; and methods of making and using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.